Lenalidomide hydrochloride
Lenalidomide hydrochloride
 Lenalidomide hydrochloride |
|
A3547-500 |
ApexBio |
500 mg |
EUR 258 |
|
Description: IC50 Value: 13 nM [1] Lenalidomideis a derivative of thalidomide introduced in 2004. Lenalidomide (Revlimid, CC-5013) is a TNF-? secretion inhibitor with IC50 of 13 nM. in vitro: Lenalidomide strongly induces IL-2 and sIL-2R production. |
) Lenalidomide-C4-NH2 (hydrochloride) |
|
HY-115446A |
MedChemExpress |
500mg |
EUR 1714 |
 Lenalidomide |
|
L044-100MG |
TOKU-E |
100 mg |
EUR 178 |
Lenalidomide |
|
L044-25MG |
TOKU-E |
25 mg |
EUR 78 |
Lenalidomide |
|
20-abx076543 |
Abbexa |
|
|
|
|
) Lenalidomide (CC-5013) |
|
A4211-100 |
ApexBio |
100 mg |
EUR 189 |
|
Description: Lenalidomide (also known as CC-5013), an oral derivative of thalidomide, is an antineoplastic agent exhibiting antitumor activity through a variety of mechanisms, including immune system activation, angiogenesis inhibition, and direct antineoplastic effects. |
Lenalidomide (CC-5013) |
|
A4211-250 |
ApexBio |
250 mg |
EUR 224 |
|
Description: Lenalidomide (also known as CC-5013), an oral derivative of thalidomide, is an antineoplastic agent exhibiting antitumor activity through a variety of mechanisms, including immune system activation, angiogenesis inhibition, and direct antineoplastic effects. |
Lenalidomide (CC-5013) |
|
A4211-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 113 |
|
Description: Lenalidomide (also known as CC-5013), an oral derivative of thalidomide, is an antineoplastic agent exhibiting antitumor activity through a variety of mechanisms, including immune system activation, angiogenesis inhibition, and direct antineoplastic effects. |
Lenalidomide (CC-5013) |
|
A4211-50 |
ApexBio |
50 mg |
EUR 154 |
|
Description: Lenalidomide (also known as CC-5013), an oral derivative of thalidomide, is an antineoplastic agent exhibiting antitumor activity through a variety of mechanisms, including immune system activation, angiogenesis inhibition, and direct antineoplastic effects. |
Lenalidomide (CC-5013) |
|
A4211-500 |
ApexBio |
500 mg |
EUR 258 |
|
Description: Lenalidomide (also known as CC-5013), an oral derivative of thalidomide, is an antineoplastic agent exhibiting antitumor activity through a variety of mechanisms, including immune system activation, angiogenesis inhibition, and direct antineoplastic effects. |
Lenalidomide (CC-5013) |
|
A4211-S |
ApexBio |
Evaluation Sample |
EUR 81 |
|
Description: Lenalidomide (also known as CC-5013), an oral derivative of thalidomide, is an antineoplastic agent exhibiting antitumor activity through a variety of mechanisms, including immune system activation, angiogenesis inhibition, and direct antineoplastic effects. |
-Lenalidomide) (R,S)-Lenalidomide |
|
1862-100 |
Biovision |
|
EUR 245 |
) Lenalidomide (Ubiquitin ligase inducer) |
|
SIH-410-10MG |
Stressmarq |
10 mg |
EUR 149 |
|
|
|
Description: The substance Lenalidomide is a ubiquitin ligase inducer. It is synthetically produced and has a purity of >98%. The pure substance is powder which is soluble in DMSO (200 mM), Water (<1 mM) and Ethanol (<1 mM).. |
Lenalidomide (Ubiquitin ligase inducer) |
|
SIH-410-50MG |
Stressmarq |
50 mg |
EUR 317 |
|
|
|
Description: The substance Lenalidomide is a ubiquitin ligase inducer. It is synthetically produced and has a purity of >98%. The pure substance is powder which is soluble in DMSO (200 mM), Water (<1 mM) and Ethanol (<1 mM).. |
-Lenalidomide) EZSolution? (R,S)-Lenalidomide |
|
B1503-10 |
Biovision |
|
EUR 120 |
 Icotinib hydrochloride |
|
I035-10MG |
TOKU-E |
10 mg |
EUR 347 |
 Kasugamycin hydrochloride |
|
K005-10G |
TOKU-E |
10 g |
EUR 276 |
Kasugamycin hydrochloride |
|
K005-1G |
TOKU-E |
1 g |
EUR 86 |
Kasugamycin hydrochloride |
|
K005-50G |
TOKU-E |
50 g |
EUR 868 |
 Methacycline hydrochloride |
|
M003-100MG |
TOKU-E |
100 mg |
EUR 139 |
Methacycline hydrochloride |
|
M003-1G |
TOKU-E |
1 g |
EUR 187 |
 Minocycline hydrochloride |
|
M008-1G |
TOKU-E |
1 g |
EUR 347 |
Minocycline hydrochloride |
|
M008-500MG |
TOKU-E |
500 mg |
EUR 200 |
 Mitoxantrone hydrochloride |
|
M010-50MG |
TOKU-E |
50 mg |
EUR 129 |
 Lomefloxacin hydrochloride |
|
L005-1G |
TOKU-E |
1 g |
EUR 74 |
Lomefloxacin hydrochloride |
|
L005-5G |
TOKU-E |
5 g |
EUR 153 |
 Daunorubicin hydrochloride |
|
D001-10MG |
TOKU-E |
10 mg |
EUR 119 |
Daunorubicin hydrochloride |
|
D001-50MG |
TOKU-E |
50 mg |
EUR 400 |
 Difloxacin hydrochloride |
|
D021-1G |
TOKU-E |
1 g |
EUR 111 |
Difloxacin hydrochloride |
|
D021-5G |
TOKU-E |
5 g |
EUR 365 |
 Demeclocycline hydrochloride |
|
D032-1G |
TOKU-E |
1 g |
EUR 174 |
Demeclocycline hydrochloride |
|
D032-250MG |
TOKU-E |
250 mg |
EUR 88 |
Demeclocycline hydrochloride |
|
D032-5G |
TOKU-E |
5 g |
EUR 539 |
 Doxycycline Hydrochloride |
|
D065-25MG |
TOKU-E |
25mg |
EUR 342 |
Doxycycline Hydrochloride |
|
D065-5MG |
TOKU-E |
5mg |
EUR 119 |
 Dalbavancin Hydrochloride |
|
D092-10MG |
TOKU-E |
10mg |
EUR 127 |
Dalbavancin Hydrochloride |
|
D092-50MG |
TOKU-E |
50mg |
EUR 380 |
 Dimethylamine hydrochloride |
|
DB0410 |
Bio Basic |
500g |
EUR 96.98 |
|
|
 Betaine hydrochloride |
|
BB0133 |
Bio Basic |
250g |
EUR 75.52 |
|
|
 Benzamidine hydrochloride |
|
BD0076 |
Bio Basic |
25g |
EUR 81.32 |
|
|
 Cefepime Hydrochloride |
|
C009-100MG |
TOKU-E |
100 mg |
EUR 267 |
 Ceftazidime Hydrochloride |
|
C020-1G |
TOKU-E |
1 g |
EUR 622 |
 Ciprofloxacin hydrochloride |
|
C032-25G |
TOKU-E |
25 g |
EUR 166 |
Lenalidomide hydrochloride
